Abstract Details
|
Jakob M. Hansen, MD, PhD
(Neurology Slagelse)
PRESENTER |
Dr. Hansen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hansen has received publishing royalties from a publication relating to health care. |
| Serapio Baca, PhD | No disclosure on file |
| Andrew Charles, MD (UCLA Goldberg Migraine Program) | Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura. The institution of Dr. Charles has received research support from NIH. Dr. Charles has received publishing royalties from a publication relating to health care. Dr. Charles has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities. |
| Matthew Farrer, PhD (University of British Columbia) | No disclosure on file |